Clinical Trial Update: Newly-diagnosed Pediatric T-cell ALL Protocol [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes a pediatric protocol for newly diagnosed T-cell acute lymphoblastic leukemia entering Phase 2/3 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• T-cell Acute Lymphoblastic Leukemia

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Acute Lymphoblastic Leukemia, Childhood Leukemia, Acute Lymphoblastic | Phase 2, Phase 3 | Status: RECRUITING